Alao, Richel Mae .

HRN: 04-32-53  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/27/2025
AMPICILLIN 1GM (VIAL)
04/27/2025
05/03/2025
IV
2g
Q6
G1P0 PU 39 0/7 Weeks AOG By LMP; PROM X 15hrs
Waiting Final Action 
04/28/2025
CEFUROXIME 1.5GM (VIAL)
04/28/2025
04/29/2025
IV
1.5 G
Q8hrs X 3 Doses
S/p Nsd With Rmle
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: